{ "ok": true, "cik": "948320", "ticker": "LFMD", "name": "LIFEMD, INC.", "filings": [ { "form": "8-K", "filed": "2026-09-15", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315226042691/0001493152-26-042691-index.htm" }, { "form": "10-Q", "filed": "2026-08-05", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315226036200/0001493152-26-036200-index.htm" }, { "form": "8-K", "filed": "2026-08-05", "items": [ "2.02 Results of Operations and Financial Condition", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315226036170/0001493152-26-036170-index.htm" }, { "form": "8-K", "filed": "2026-06-22", "items": [ "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315226029503/0001493152-26-029503-index.htm" }, { "form": "10-Q", "filed": "2026-05-06", "items": [], "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315226021536/0001493152-26-021536-index.htm" }, { "form": "8-K", "filed": "2026-05-06", "items": [ "2.02 Results of Operations and Financial Condition", "7.01 Regulation FD Disclosure", "9.01 Financial Statements and Exhibits" ], "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315226021520/0001493152-26-021520-index.htm" } ], "events12m": 10, "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000948320.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=948320" }, "license": "Figures as filed with the SEC. Card text CC BY 4.0, POPS4.", "notAdvice": "Reporting, not investment advice. No price targets, no buy or sell views.", "edgar": "🫧 Edgar looked up LIFEMD, INC. ($LFMD). Last filing: 8-K (7.01 Regulation FD Disclosure), 2026-09-15. 10 event filings (8-K) in the past twelve months. Auditor change (8-K Item 4.01) filed 2025-08-21.", "auditor": { "changes": [ { "filed": "2025-08-21", "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315225012214/0001493152-25-012214-index.htm" }, { "filed": "2025-04-25", "url": "https://www.sec.gov/Archives/edgar/data/948320/000164117225006228/0001641172-25-006228-index.htm" } ], "nonReliance": [], "restatedSince": null }, "metrics": { "fiscalYearEnd": "2025-12-31", "revenue": 194055198, "revenueGrowth1y": 0.2533916188422247, "revenueGrowthPerYear": 0.20228013427281577, "yearsOfData": 5, "operatingMargin": -0.0395232597685943, "operatingMarginPrior": -0.1317752939909378, "netMargin": 0.08049148469601933, "operatingCashFlow": 8280175, "capitalSpending": 1870668, "freeCashFlow": 6409507, "researchAndDevelopment": null, "researchShareOfRevenue": null, "cash": 36786318, "longTermDebt": null, "longTermDebtChange": null, "revenueHistory": [ { "fiscalYearEnd": "2021-12-31", "revenue": 92875806 }, { "fiscalYearEnd": "2022-12-31", "revenue": 119033520 }, { "fiscalYearEnd": "2023-12-31", "revenue": 152547006 }, { "fiscalYearEnd": "2024-12-31", "revenue": 154824075 }, { "fiscalYearEnd": "2025-12-31", "revenue": 194055198 } ], "totalEquity": 23156580, "totalAssets": 70411319, "equityRatio": 0.3288758161170081, "returnOnEquity": 0.6745292698662756, "dividendsPaid": 3106250, "payoutRatio": 0.19886629725071225, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "priceBased": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown.", "range80": { "low": 186005848.29392773, "high": 298958182.6407728, "baseline": 235808631.20426944, "n": 4309, "band": "b01" }, "ifPaceHeld": { "low": 186005848.29392773, "high": 298958182.6407728 } }, "edgarette": "🔖 Exposure: revenue $194.1M (FY2025). Experience: revenue up 25.3% on the year, up 20.2% a year over 4 years; operating margin -4.0%, up from -13.2%. Soundness: equity 32.9% of assets, return on equity 67.5%, payout 19.9% of profit. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $186.0M and $299.0M next year (method v3, set from 4,309 SEC company-years; on a year the method never saw, 83% landed inside). A range, not a forecast. Against peers (54 filers, $50M+ revenue, its industry group): operating margin -4.0% against a 2.0% median; growth 25.3% against 13.0%.", "peers": { "sic": 8011, "sicDescription": "Services-Offices & Clinics of Doctors of Medicine", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "summary": "Lifemd (LFMD) grew revenue 25.3% in FY2025 to $194 million, operating margin -4.0% against a 2.0% median for services-offices & clinics of doctors of medicine, equity 32.9% of assets. Every figure is from the company’s own annual report filed with the SEC.", "chart": "
LIFEMD, INC. against its own record and its peers
Operating marginPeer median 2.0%-4.0%Revenue, on the yearPeer median 13.0%25.3%Equity of assetsPeer median 44.2%32.9%Return on equityPeer median 1.6%67.5%Payout of profitPeer median 19.3%19.9%Gold tick: the median of 13–59 peers with $50M+ revenue in services-offices & clinics of doctors of medicine
", "chartHorizon": "
Handed back now, or kept to compound
Of each dollar of profit19.9% paid out80.1% keptGrowth its own profit can fund54.0%retained x return on equityRevenue growth it managed25.3%last year, for comparison

Gold is paid out to shareholders; navy is kept in the business. Retained profit times return on equity is the pace a company can fund from itself. Facts from the filings, not a recommendation.

", "backtest": { "tests": 10, "hits": 4, "rate": 0.4, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:19:15.920Z", "hash": "ca1d8183ecf2f41b", "status": "open" }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "schema": "pops4.edgarette.card/1", "card": { "summary": "Lifemd (LFMD) grew revenue 25.3% in FY2025 to $194 million, operating margin -4.0% against a 2.0% median for services-offices & clinics of doctors of medicine, equity 32.9% of assets. Every figure is from the company’s own annual report filed with the SEC.", "exposure": { "fiscalYearEnd": "2025-12-31", "revenue": 194055198, "totalDebt": null, "cash": 36786318 }, "experience": { "revenueGrowth1y": 0.2533916188422247, "revenueGrowthPerYear": 0.20228013427281577, "operatingMargin": -0.0395232597685943, "operatingMarginPrior": -0.1317752939909378, "netMargin": 0.08049148469601933, "freeCashFlow": 6409507 }, "soundness": { "equityRatio": 0.3288758161170081, "returnOnEquity": 0.6745292698662756, "payoutRatio": 0.19886629725071225, "dividendPerShare": null, "dividendYearsRising": null, "dividendCut": null, "note": "Dividend yield, price/earnings and price/book need a share price. The boards carry filings only, so they are not shown." }, "peers": { "sic": 8011, "sicDescription": "Services-Offices & Clinics of Doctors of Medicine", "calendarYear": 2025, "minRevenue": 50000000, "depth": 2, "group": "80", "growth": [ 0.1303, 61 ], "opMargin": [ 0.0199, 54 ], "equityRatio": [ 0.4419, 59 ], "returnOnEquity": [ 0.0155, 49 ], "payoutRatio": [ 0.1928, 13 ] }, "credibility": { "auditedYears": 5, "weight": "reasonable", "standard": "ASOP No. 25", "nonReliance": null, "auditorChange": { "filed": "2025-08-21", "url": "https://www.sec.gov/Archives/edgar/data/948320/000149315225012214/0001493152-25-012214-index.htm" } }, "range": { "low": 186005848.29392773, "high": 298958182.6407728, "baseline": 235808631.20426944, "coverage": 0.8, "method": "v3", "basis": "next fiscal year revenue: baseline = revenue x (1 + mean of one-year and three-year pace); range = 10th to 90th percentile of how SEC company-years of the same size band actually turned out", "calibratedOn": { "companyYears": 4309, "sizeBand": "b01" }, "kind": "a calibrated range, not a forecast; no view on the share price", "track": { "backtest": { "tests": 10, "hits": 4, "rate": 0.4, "method": "v3", "note": "hindsight: past years, same calibrated range. The range was calibrated on 2022-2024 SEC data, so years in that window are partly in-sample." }, "registry": { "logged": "2026-09-20T15:19:15.920Z", "hash": "ca1d8183ecf2f41b", "status": "open" }, "scorecard": "https://www.pops4.com/boards/scorecard" } }, "caution": "Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.", "sources": { "facts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000948320.json", "filings": "https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=948320" } }, "definitions": { "operatingMargin": "Operating income divided by revenue.", "netMargin": "Net income divided by revenue.", "freeCashFlow": "Cash from operations minus spending on property and equipment.", "researchShareOfRevenue": "Research and development expense for the year as a share of revenue, both as filed.", "equityRatio": "Shareholders equity as a share of total assets, both as filed. Higher means less of the company is owed to someone else.", "returnOnEquity": "Net income for the year against shareholders equity at year end.", "payoutRatio": "Dividends paid as a share of net income, in the year the cash went out.", "dividendYearsRising": "Consecutive years, counted back from the last on record, in which dividend per share rose. A fall ends the run and is reported as dividendCut.", "revenueGrowthPerYear": "Compound annual growth between the first and latest fiscal years shown.", "credibility": "How much weight a record deserves, in the actuarial sense (ASOP No. 25): more audited years, more weight.", "peers": "Medians of SEC filers with $50M+ revenue in the same industry code (SIC), narrowest group with at least 8 filers, calendar-year figures from SEC XBRL frames.", "backtest": "The same if-the-pace-held arithmetic applied to the company's own past years, scored against what it actually reported next. Hindsight, and labelled so." } }